Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf233 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Satoshi Takamori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
Tumour location can affect clinicians’ decisions regarding the surgical procedure, especially when choosing between lobectomy and segmentectomy. The biological behaviour of clinical stage I non-small cell lung cancer (NSCLC) may differ based on tumour location. We aimed to explore the biological behaviour of centrally located (CL) clinical stage I NSCLC and to identify which surgical procedure is more appropriate for such tumours.
Methods
This retrospective study included 719 patients who underwent curative operations for stage I NSCLC between April 2004 and December 2023. The biological behaviour of the tumours was analysed based on tumour location. Overall and recurrence-free survivals in patients who underwent lobectomy or more extensive procedures, including hilar and mediastinal lymph node dissection, were assessed based on tumour location.
Results
A total of 124 (17.2%) and 595 (82.8%) patients were included in the CL and peripherally located groups, respectively. The CL group had a significantly higher standardized uptake value maximum on positron emission tomography/computed tomography, a higher-grade adenocarcinoma subtype, and a higher frequency of lymph node metastasis than the peripherally located group. In multivariable analysis, CL and radiologically pure solid tumours (consolidation/tumour ratio = 1) were significant factors for occult lymph node metastasis. No significant difference was observed in survival based on tumour location.
Conclusions
Centrally located clinical stage I NSCLCs tend to be hypermetabolic and have a potential risk of lymph node metastasis. Lobectomy could be a better treatment option for CL clinical stage I NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
- Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata 990-2292, Japan.
ORCID-Profile: Satoshi Takamori, Jun Suzuki, Satoshi Shiono
Zitieren
APA
Takamori, S., Nakatsuka, M., Watanabe, H., Suzuki, J., Endo, M., & Shiono, S. (2025). Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf233
Vancouver
Takamori S, Nakatsuka M, Watanabe H, Suzuki J, Endo M, Shiono S. Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf233
BibTeX
@article{Takamori2025,
author = {Takamori, Satoshi and Nakatsuka, Marina and Watanabe, Hikaru and Suzuki, Jun and Endo, Makoto and Shiono, Satoshi},
title = {Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf233}
}
EUVIMED